Stay updated with breaking news from Mylab Discovery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HBV/HCV test kits marketThe HIV/HBV/HCV test kits market sale is projected to generate US$ 11,573,9 million in revenue in 2033 and US$ 6,568.3 million in revenue in 2023. Over the course of the projection year, sales of HIV/HBV/HCV test kits are anticipated to rise at a noteworthy compound annual growth rate (CAGR)...
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Smart or AI In-Vitro Diagnostics Market Size, Share &...
Dr. Minal Dakhave Bhosale's passion for public health burned bright from an early age. This led her to become the driving force behind the development of a groundbreaking Covid-19 testing kit at a young age of 33.The urgency was palpable then, ...
Increasing incidence of gynecological disorders to drive the market. The fertility and pregnancy rapid test kit market in the United States is expected to garner a 5.2% CAGR during the forecast period.NEWARK, Del, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The fertility and pregnancy rapid test kit market is anticipated to be valued at US$ 990.4 million by 2023. The market is anticipated to exhibit a 5% CAGR throughout the forecast period, reaching a valuation of US$ 1,609.1 million by 2033. The fertilit
On Monday, 2062 stocks advanced, 1675 declined and 170 remained unchanged, with an advance decline ratio of 1.23 on the Bombay Stock Exchange (BSE), indicating a negative closing of stocks in broader markets. Domestic equities prompted buying, notably in the IT sector, as a result of the global market's recovery following a big slump.